After the publication of this work [1], we noted that owing to an inadvertent mistake, the description of the chemotherapy schedule shown in the Methods was different from that shown in the Abstract and the duration of S-1 treatment in the initial chemoradiotherapy was inadequately described in Figure 1 . Therefore, Methods and Figure 1 were modified accordingly.
Correction
After the publication of this work [1] , we noted that owing to an inadvertent mistake, the description of the chemotherapy schedule shown in the Methods was different from that shown in the Abstract and the duration of S-1 treatment in the initial chemoradiotherapy was inadequately described in Figure 1 . Therefore, Methods and Figure 1 were modified accordingly.
In the "Chemoradiotherapy" section in the Methods, the 1st and 3rd paragraphs should read as follows:
"The chemoradiotherapy protocol consisted of administration of S-1 plus biweekly cisplatin and radiation ( Figure 1 ). The initial chemoradiotherapy schedule was for 6 weeks: S-1 was orally administered twice daily from the evening of day 1 to the morning of day 15, and the total dose was based on the patient's body surface area (BSA), as follows: <1.25 m 2 , 80 mg; 1.25-1.5 m 2 , 100 mg; and >1.5 m 2 , 120 mg. An escalating dose of cisplatin was administered by infusion over 1 h on days 1 and 15 without infusional hydration. The starting dose (level 1) of cisplatin was 15 mg/m 2 , the second dose (level 2) was 20 mg/m 2 , and the third dose (level 3) was 25 mg/m 2 ." "After initial chemoradiotherapy, one cycle of combination chemotherapy with S-1 plus biweekly cisplatin was delivered. This consisted of 42 days of S-1 administered from the evening of day 1 to the morning of day 29 and of cisplatin administered on days 1, 15, and 29."
In " Figure 1 ," based on the description in the manuscript, the duration of S-1 treatment in the initial chemoradiotherapy was revised to 1-15 days from 1-22 days (Figure 1 ). 
